Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,450 total articles

LIXTE Joins Russell Microcap Index

LIXTE Joins Russell Microcap Index

LIXTE Biotechnology Holdings, Inc. has been added to the Russell Microcap Index as of June 26, 2026, reflecting its recent growth and strategic transformation from biotechnology to an AI energy infrastructure equipment and services platform. This inclusion is expected to increase visibility among institutional investors and support LIXTE's efforts …

KULR Technology Group Reaffirms Non-Dilutive Growth Strategy, Extends At-the-Market Offering Pause Through September 2026

KULR Technology Group Reaffirms Non-Dilutive Growth Strategy, Extends At-the-Market Offering Pause Through September 2026

KULR Technology Group has extended the pause on its at-the-market equity offering program through September 2026 as part of its non-dilutive growth strategy, prioritizing shareholder value and operational execution. The company plans to fund growth through existing liquidity and Bitcoin asset sales to scale its battery systems across space, defense…

Maris-Tech Awarded a Government Defense Contract as Prime Contractor

Maris-Tech Awarded a Government Defense Contract as Prime Contractor

Maris-Tech Ltd., an advanced defense technology firm, announced it has been awarded a government contract as prime contractor to develop and supply a MIL-STD vehicle-mounted audio-based system for armored fighting vehicles. Valued at approximately $350,000, the contract marks an important strategic milestone as Maris-Tech expands beyond its core ed…

Abacus Global Management’s Defamation Suit Against Coventry and its Chairman Alan Buerger Advances in U.S. District Court

Abacus Global Management’s Defamation Suit Against Coventry and its Chairman Alan Buerger Advances in U.S. District Court

Abacus Global Management announced that a U.S. Federal Court denied Coventry First LLC's motion to dismiss a defamation and anticompetitive conduct lawsuit filed by Abacus. The case will proceed with depositions of Coventry executives including Chairman Alan Buerger. Abacus alleges Coventry engaged in a deliberate campaign to damage its reputation …

Quantum Cyber Approves Acquisition of Equity Stake in SpaceX

Quantum Cyber Approves Acquisition of Equity Stake in SpaceX

Quantum Cyber N.V., a Nasdaq-listed defense technology company specializing in AI-powered autonomous systems, announced its board has approved the engagement of investment bankers to facilitate acquiring an equity stake in SpaceX. This strategic move aims to integrate SpaceX’s space-based communications and sensing capabilities with Quantum Cyber’s…

Xunlei Announces US$20 Million Share Repurchase Program

Xunlei Announces US$20 Million Share Repurchase Program

Xunlei Limited, a Nasdaq-listed technology company specializing in distributed cloud services in China, announced a new $20 million share repurchase program effective July 1, 2026. Funded from cash reserves of approximately $303.6 million, the program aims to buy back ADSs or common shares over 12 months to enhance shareholder value and demonstrate…

XCharge Announces Pricing of $4.375 Million Registered Direct Offering with a Single Global Institutional Investor

XCharge Announces Pricing of $4.375 Million Registered Direct Offering with a Single Global Institutional Investor

XCHG Limited, an EV charging and energy solutions company listed on Nasdaq as XCH, has entered into an agreement for a $4.375 million registered direct offering of 7 million ADSs to a single global institutional investor. The offering proceeds will support working capital and general corporate purposes, with closing expected on June 29, 2026, subje…

Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma

Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma

Replimune Group, Inc. announced the FDA has accepted for review the resubmitted Biologics License Application (BLA) for RP1 in combination with nivolumab to treat advanced melanoma. The FDA classified the resubmission as a complete, class 1 response with an action goal date of August 2, 2026, and plans for an advisory committee meeting in late July…

Mount Logan Capital Inc. to Join the Russell Microcap® Index

Mount Logan Capital Inc. to Join the Russell Microcap® Index

Mount Logan Capital Inc. announced it will be added to the Russell Microcap® Index starting June 29, 2026, following its Nasdaq listing in 2025. This inclusion marks a significant milestone, expected to increase investor awareness and broaden participation in U.S.-based investment strategies. Mount Logan focuses on integrated alternative asset mana…

Upexi Added to the Russell Microcap® Index

Upexi Added to the Russell Microcap® Index

Upexi, Inc. (NASDAQ: UPXI), which specializes in a digital asset treasury strategy centered on accumulating Solana (SOL), has been added to the Russell Microcap® Index effective June 29, 2026. This inclusion signifies recognition of Upexi’s growth and broadens its exposure to institutional investors and funds tracking the index. The company holds o…

IP Strategy Highlights Story Foundation's Transition to The DATA Foundation and Launch of DATA Network

IP Strategy Highlights Story Foundation's Transition to The DATA Foundation and Launch of DATA Network

IP Strategy Holdings, Inc. announced the strategic transition of Story Foundation to The DATA Foundation, launching the DATA Network along with related platforms Trace, Kled, Poseidon, and Numo. These initiatives aim to establish an integrated infrastructure for sourcing, verifying, licensing, and monetizing AI training data with blockchain-based p…

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

Vivani Medical, a clinical-stage biopharmaceutical company, announced the appointment of August Moretti to its board of directors, replacing retiring board member Dr. Dean Baker. This leadership change coincides with the company's ongoing development of its lead semaglutide implant, NPM-139, and its proprietary NanoPortal technology for chronic dis…

Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Axsome Therapeutics has begun dosing the first patient in its FOCUS-3 Phase 3 clinical trial evaluating solriamfetol as a treatment for adolescents with ADHD. This trial will assess the efficacy and safety of two doses of solriamfetol in approximately 468 patients aged 12 to under 18 years, with the goal of addressing a significant unmet medical ne…

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

Beyond Air, Inc. reported a 107% year-over-year revenue increase to $7.7 million for fiscal year 2026 and a strong 66% revenue growth in the fourth quarter. The company is transitioning its fiscal year-end to December 31 and provided optimistic revenue guidance of $8 million for 2026 and $16-$18 million for 2027, anticipating over 110% growth suppo…

Tilray Medical Expands Medical Cannabis Access for Veterans Through Lyphe Clinic at Aldershot’s Armed Forces Weekend

Tilray Medical Expands Medical Cannabis Access for Veterans Through Lyphe Clinic at Aldershot’s Armed Forces Weekend

Tilray Medical, a division of Tilray Brands, expands its medical cannabis access for UK veterans by introducing the 'Lyphe for Veterans' program at the Aldershot Armed Forces Weekend. The program removes financial and access barriers for veterans seeking medically regulated cannabis treatments, reflecting Tilray's commitment to responsible healthca…

Aurora Mobile’s JPush Empowers Yuanda Information’s Caiyuan Gungun App with Millisecond-Level, Precise User Engagement

Aurora Mobile’s JPush Empowers Yuanda Information’s Caiyuan Gungun App with Millisecond-Level, Precise User Engagement

Aurora Mobile Limited partners with Hebei Yuanda Information Technology to integrate its JPush intelligent push notification system into the Caiyuan Gungun App. This technology upgrade delivers millisecond-level message delivery with high concurrency support across multiple device ecosystems, improving timely, personalized financial information dis…